New Macrocyclic Lathyrane Diterpenes, from Euphorbia lagascae, as Inhibitors of Multidrug Resistance of Tumour Cells

Abstract

The new macrocyclic lathyrane diterpenes latilagascenes A and B (1 and 2), the diacetylated derivative of 2, latilagascene C (3), and the known diterpenes ent-16α,17-dihydroxyatisan-3-one (4) and ent-16α,17-dihydroxykauran-3-one (5), isolated from the methanol extract of Euphorbia lagascae, were examined for their effects on the reversal of multidrug resistance (MDR) on mouse lymphoma cells. Among the active lathyrane derivatives 1 - 3, compound 2 displayed the highest inhibition of rhodamine 123 efflux of human MDR1 gene transfected mouse lymphoma cells when compared to the untreated cells or the positive control verapamil. The new compounds are the first macrocyclic lathyrane diterpenes showing oxidation at C-16, whose structures were characterized by extensive spectroscopic methods, including 2D NMR experiments (¹H-¹H COSY, HMQC, HMBC and NOESY). The known phenolic compounds vanillic acid (6), p-salicylic acid (7), isofraxidin (8) and cleomiscosin A (9) were also isolated from this species.

Euphorbia lagascae - lathyrane - diterpenes - phenolic compounds - multidrug resistance - P-glycoprotein

References

• 1 Grossi A, Biscardi M. Reversal of MDR by verapamil analogues.  Hematology. 2004;  9 47-56
• 2 Gottesman M M, Fojo T, Bates S E. Multidrug resistance in cancer: role of ATP-dependent transporters.  Nat Rev Cancer. 2002;  2 48-58
• 3 Teodori E, Dei S, Scapecchi S, Gualtieri F. The medicinal chemistry of multidrug resistance (MDR) reversing Drugs.  Il Farmaco. 2002;  57 385-415
• 4 Cahoon E B, Ripp K G, Hall S E, McGonigle B. Transgenic production of epoxy fatty acids by expression of a cytochrome P450 enzyme from Euphorbia lagascae seed.  Plant Physiol. 2002;  128 615-24
• 5 Ferrigni N R., McLaughlin J L, Powell R G, Smith C R. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae .  J Nat Prod. 1984;  47 347-52
• 6 Valente C, Ferreira M JU, Abreu P M, Gyémánt N, Ugocsai K, Hohmann J. et al . Pubescenes, jatrophane diterpenes, from Euphorbia pubescens with multidrug resistance reversing activity on mouse lymphoma cells.  Planta Med. 2004;  70 81-4
• 7 Hohmann J, Molnár J, Rédei D, Evanics F, Forgó P, Kálmán A. et al . Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of MDR of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species.  J Med Chem. 2002;  45 2425-31
• 8 Corea G, Fattorusso E, Lanzotti V, Motti R, Simon P N, Dumontet C. et al . Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A.  J Med Chem. 2004;  47 988-92
• 9 Appendino G, Della Porta C, Conseil G, Sterner O, Mercalli E, Dumontet C. et al . A new P-glycoprotein inhibitor from the caper spurge (Euphorbia lathyris).  J Nat Prod. 2003;  66 140-2
• 10 Coenwell M M, Pastan I, Gottesmann M M. Certain calcium channel blockers bind specifically to multidrug-resistance human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.  J Biol Chem. 1987;  262 2166-70
• 11 Weaver J L, Szabo G, Pine P S, Gottesman M M, Goldenberg S, Aszalos A. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multidrug transporter.  Int J Cancer. 1993;  54 456-61
• 12 Kessel D. Exploring multidrug resistance using rhodamine 123. Cancer Commun 1989: 145-9
• 13 Lieu L G, Tan R X. New jatrophane diterpenoid esters from Euphorbia turczaninowii .  J Nat Prod. 2001;  64 1064-8 and related references cited therein
• 14 Uemura D, Nakayama Y, Shizuri Y, Hirata Y. The structure of new lathyrane diterpenes, Jolkinols A, B, C and D from Euphorbia jolkini Boiss. Tetrahedron Lett 1976: 4593-6
• 15 Seip E, Hecker E. Lathyrane type diterpenoid esters from Euphorbia characias .  Phytochemistry. 1983;  22 1791-5
• 16 Vasas A, Hohmann J, Forgo P, Szabo P. New tri- and tetracyclic diterpenes from Euphorbia villosa .  Tetrahedron. 2004;  60 5025-30
• 17 Lal A, Cambie R, Rutledge P, Woodgate P. Ent-atisane diterpenes from Euphorbia fidjiana .  Phytochemistry. 1990;  29 1925-35
• 18 Gustafson K, Munro M, Blunt J. HIV inhibitory natural products. 3. Diterpenes from Homalanthus acuminatus and Chrysobalanus icaco .  Tetrahedron. 1991;  47 4547-54
• 19 Huang Z, Dostal L, Rosazza J. Mechanisms of ferulic acid conversions to vanillic and guaiacol by Rhodotorula ombra .  J Biol Chem. 1993;  268 23 954-8
• 20 Tan J, Bednarek P, Liu J, Schneider B, Svatôs A, Hahlbrock K. Universally occurring phenylpropanoid and species-specific indolic metabolites in infected and uninfected Arabidopsis thaliana roots and leaves.  Phytochemistry. 2004;  65 691-9
• 21 Panichayupakaranant P, Noguchi H, De-Eknamkul W, Sankawa U. Naphthoquinones and coumarins from Impatiens Balsamina root cultures.  Phytochemistry. 1995;  40 1141-3
• 22 Ray A, Chattopadhyay S, Kumar S, Konno C, Kiso Y, Hikino H. Structure of cleomiscosins, coumarinolignoids of Cleome viscosa seeds.  Tetrahedron. 1985;  41 209-14
• 23 Klopman G, Shi L M, Ramu A. Quantitative structure-activity relationship of multidrug resistance reversal agents.  Mol Pharmacol. 1997;  52 323-34
• 24 Seelig A, Landwojtowicz E. Structure-activity relationship of P-glycoprotein substrates and modifiers.  Eur J Pharm Sci. 2000;  12 31-40
• 25 Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M. et al . Modified jatrophane diterpenes as modulators of multidrug resistance from Euphorbia dendroides .  Bioorg Med Chem. 2003;  11 5221-7
• 26 Corea G, Fattorusso E, Lanzotti V, Motti R, Simon P N, Dumontet C. et al . Structure-activity relationships for Euphocharactins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein.  Planta Med. 2004;  70 657-65
• 27 Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M. et al . Jatrophane diterpenes as P-glycoprotein inhibitors. First insights of structure-activity relationships and discovery of a new, powerful lead.  J Med Chem. 2003;  46 3395-402